US Stocks
/
Adagene Inc. Share Price

Adagene Inc. Share Price

NASDAQ: ADAG
$2.75
-$0.02 (-0.72%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Adagene Inc. Stock Performance

Open
$2.78
Prev. Close
$2.77
Circuit Range
N/A
Day Range
$2.63 - $2.85
Year Range
$1.33 - $4.85
Volume
34,578
Average Traded
$2.72

Adagene Inc. Share Price Today

As of 10 October 2026, Adagene Inc.'s share price is $2.75. The stock opened at $2.78, compared to its previous close of $2.77. During today's trading session, Adagene Inc.'s share price traded between $2.63 and $2.85, with an average price of $2.74. Over the past 52 weeks, the stock has recorded a high of $4.85 and a low of $1.33. In terms of performance, Adagene Inc.'s share price has declined by 24.93% over the last six months and is up 54.78% on a year-on-year basis.

Adagene Inc. Share Price Chart

$2.63$2.85
L
Show Current Price
H

Adagene Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$7.67B
Return On Equity (TTM)
N/A
Profit Margin
-229.60%
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Adagene Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$9.29$18.11$0.10$7.67
Net Profit-$79.97-$18.95-$33.42-$17.61
Net Profit Margin-860.82%-104.64%-33420.00%-229.60%
Income ChangeN/A76.30%-76.36%47.31%

About Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

Adagene Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$3.09
$2.75
-14.20%
Sep 2026
$3.58
$3.21
-18.14%
Aug 2026
$3.69
$3.92
+4.54%
Jul 2026
$4.02
$3.75
-11.47%
Jun 2026
$3.80
$4.23
+6.42%
May 2026
$3.74
$3.98
+8.31%
Apr 2026
$4.13
$3.67
-9.16%
Mar 2026
$2.95
$4.04
+32.03%
Feb 2026
$2.70
$3.06
+10.47%
Jan 2026
$1.78
$2.77
+46.56%
Dec 2025
$2.07
$1.89
-8.70%
Nov 2025
$1.77
$2.07
+16.29%

ADAG Share Price FAQs

What is Adagene Inc. share price today?

chevron-up
Adagene Inc. share price today is $2.75 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Adagene Inc. stock?

chevron-up
The 52 week high of Adagene Inc. stock is $4.85, while the 52 week low is $1.33 as of 10 Oct '26.

What is the 5 year returns of ADAG?

chevron-up
The 5 year returns of ADAG is -75.62% as on 10 Oct '26.

What is the high & low stock price of ADAG today?

chevron-up
ADAG stock price hit a high of $2.85 and low of $2.63 as of 10 Oct '26.

Can I buy ADAG shares in India?

chevron-up
Yes. You can buy ADAG in India by opening an international trading account.